S&P 500: 666.06 -1.5% NASDAQ 100: 597.26 -1.7% Dow Jones: 467.48 -1.5%

Metlife - Q4 2025 13F Filings

ME

Metlife INC

CIK: 0001099219
Address: New York New York 200 Park Avenue
$12.15 M
Portfolio Value
6
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 02/12/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. SPY Spdr S&P 500 Etf Trust
+$183,880.58
2. ECH Ishares Msci Chile Etf
+$23,088.59

Top Sells

Q4 2025
1. ILF Ishares Latin America 40 Etf
−$54,657.51
2. IEV Ishares Europe Etf
−$22,432.38
3. EPP Ishares Msci Pacific Ex-Japan Etf
−$10,917.9
4. EWJ Ishares Msci Japan Etf
−$10,804.59

Asset Allocation

Stocks/ETFs
+9.24%
$12.15 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Metlife Q4 2025 Filing Summary

Metlife INC filed its 13F report for Q4 2025 on February 12, 2026. The portfolio totaled 12.15 M reflecting a +9.24% change from the prior quarter, spanning 6 assets. The top 10 holdings comprised 100.0% of the portfolio. No significant position changes were reported during the quarter.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Metlife’s Q4 2025 Filing

Metlife submitted their Form 13F-HR for the Q4 2025 period on 02/12/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Metlife reported a managed portfolio value of 12.15 M, consisting of 6 individual positions.

This page displays the raw filing documents. To see which stocks Metlife bought or sold during Q4 2025, please visit Metlife's Portfolio Analysis page.